Bumper Offer - Urjas oil Just @ Rs. 1
Sizlac is a prescription drug, available for use as Tablet, Injection. Primarily, it is used for the treatment of Epilepsy. Secondary and off-label uses of Sizlac have also been mentioned below.
The right dosage of Sizlac depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
While these are the most often observed Sizlac side effects, there are can be others also. These have been listed below. Normally, these side effects of Sizlac are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Sizlac's effect is Moderate during pregnancy and Severe for lactating mothers. Warnings related to Sizlac's effects on the liver, heart and kidney, if any, have been listed below.
Sizlac is contraindicated in people with pre-existing medical conditions like Depression as it can result in adverse effects. Other conditions have been mentioned below in the Sizlac contraindications section.
Besides this, Sizlac may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to the above precautions for Sizlac, it is important to know that it is not safe while driving, and is not habit-forming.
Sizlac is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Sizlac is used -
Moderate
Mild
Is the use of Sizlac safe for pregnant women?
Sizlac may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Sizlac again without your doctor's advice.
Is the use of Sizlac safe during breastfeeding?
Sizlac may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Sizlac on the Kidneys?
Sizlac does not damage the kidneys.
What is the effect of Sizlac on the Liver?
Sizlac is rarely harmful for the liver.
What is the effect of Sizlac on the Heart?
Sizlac has very mild side effects on the heart.
Sizlac should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Sizlac unless your doctor advises you to do so -
Is this Sizlac habit forming or addictive?
You may get addicted to Sizlac. Therefore, before taking it, consult your doctor.
Is it safe to drive or operate heavy machinery when consuming?
After taking Sizlac you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Sizlac is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Yes, this Sizlac works for mental disorders.
Interaction between Food and Sizlac
Taking Sizlac with food does not cause any problems.
Interaction between Alcohol and Sizlac
Taking alcohol with Sizlac can be dangerous.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 737-738
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 421
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vimpat® (lacosamide)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 737-738
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 421
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vimpat® (lacosamide)
